Avicanna files patent for cannabinoid med that reduces epileptic seizures, sudden death

Mugglehead
By Natalia Buendia CalvilloSep 24, 2021, 4:05 pm268 pts
Avicanna Inc. (TSX: AVCN) (OTCQX: AVCNF) (FSE: 0NN) is moving to patent a novel cannabinoid formulation that reduces epilepsy-caused seizures and sudden death. On Friday, the Toronto-based biopharmaceutical firm said it recently filed an application with the United States Patent and Trademark Office.…

Read Article Share
Share Article
- email
- twitter
- facebook
- pocket
- reddit
- tumblr
- linkedin
- pinterest

Trending Today on NewsBudz

About NewsBudz

NewsBudz is your go-to app for daily cannabis news, covering everything from medical marijuana breakthroughs to recreational cannabis trends and legalization updates.

Our platform aggregates content from over 30 top-tier cannabis news outlets to deliver a curated stream of the latest headlines, insights, and developments across the marijuana and hemp industries.

Whether you're interested in policy reform, health research, cannabis business, CBD, delta 9 products or lifestyle stories, NewsBudz keeps you informed and connected. Accessible on the web and mobile, NewsBudz makes it easy to explore, read, and share cannabis news anytime, anywhere.